However, following the adjustment for potential confounding factors, they concluded that no causal link exists between GLP-1 RAs and suicidality 37
Obstructive sleep apnea, obesity hypoventilation syndrome, and asthma are prevalent in this population
Exenatide Once Weekly for Alcohol Use Disorder Investigated in a Randomized, Placebo-Controlled Clinical Trial
Weight reduction that is substantial (14 %) and rapid (over 34 months) is associated with significant bone loss [67], while more moderate and slower weight reduction may better preserve bone mass [68]
doi: 10.1176/appi.psy.50.6.613
In this review, youll gain deep insight into Nooms unique microdose and full-dose GLP-1 protocols, real user experiences, clinical effectiveness, cost structure, and how Noom stacks up against competitors